Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Phio Pharmaceuticals

PHIO

1.0500.94% ( -0.010 )

Closed: Aug 18, 16:00:00 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Phio Pharmaceuticals announces annual shareholder meeting
PUBT·Aug 14 at 03:08 PM
PHIO-0.94%
Phio Pharma wins U.S. patent allowance for BRD4-targeting INTASYL compound PH-894
PUBT·Aug 11 at 06:04 AM
PHIO-0.94%
Phio Pharmaceuticals | 8-K: FY2026 Q2 Revenue: USD 0
Earnings Watch·Aug 6 at 04:11 PM
PHIO-0.94%
Phio net loss widens to $4.14 million in Q2 FY26
PUBT·Aug 6 at 03:37 PM
PHIO-0.94%
Phio Pharmaceuticals director Ronald Todd Plott files initial beneficial ownership statement
PUBT·Jul 30 at 03:02 PM
PHIO-0.94%
Phio Pharma corrects date for Renmark virtual non-deal roadshow presentation
PUBT·Jul 22 at 11:31 AM
PHIO-0.94%
Phio Pharmaceuticals adds dermatology expert to board
Tip Ranks·Jul 21 at 06:28 AM
PHIO-0.94%
Phio Pharmaceuticals Announces Appointment of Dr. R. Todd Plott to the Board of Directors | PHIO Stock News
StockTitan·Jul 20 at 10:00 PM
PHIO-0.94%
Phio Pharmaceuticals jumps 9% after-hours on INTASYL patent wins
US Stock Market Update·Jul 15 at 05:41 PM
PHIO-0.94%
Phio Pharmaceuticals (PHIO) Surges 9% in After-Hours Trading on INTASYL Patent Approvals
US Stock Market Update·Jul 15 at 04:31 PM
PHIO-0.94%
Phio Pharmaceuticals tumbles 11% on INTASYL patent approvals
US Stock Market Update·Jul 15 at 02:01 PM
PHIO-0.94%
Phio Pharmaceuticals (PHIO.US) tumbles 8% during regular trading
US Stock Market Update·Jul 15 at 08:52 AM
PHIO-0.94%
Phio Pharmaceuticals Announces Patent Milestone with Multiple Notices of Allowance and Grant Decision | PHIO Stock News
StockTitan·Jul 14 at 10:00 PM
PHIO-0.94%